Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis

Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis

Abstract. Background:. Clinical outcomes of undifferentiated arthritis (UA) are diverse, and only 40% of patients with UA develop rheumatoid arthritis (RA) after 3 years. Discovering predictive markers at disease onset for further intervention is critical. Therefore, our objective was to analyze the...

Full description

Bibliographic Details
Main Authors: Chun Li, Yan Zhang, Hui Song, Jie Gao, Dong-Bao Zhao, Qi Zhu, Dong-Yi He, Li Wang, Xiang-Pei Li, Xu-Dong Liu, Wei-Guo Xiao, Xin-Yu Wu, Hua-Xiang Wu, Wei Tu, Shao-Xian Hu, Xin Wang, Zhi-Jun Li, Zhi-Min Lu, Zhan-Yun Da, Bo Liang, Xiao-Min Liu, Jin-Wei Zhao, Ling Li, Feng Han, Wu-Fang Qi, Wei Wei, Xu Ma, Zhen-Bin Li, Gui-Min Zheng, Feng-Xiao Zhang, Yi Li, You-Lian Wang, Guang-Hui Ling, Jin-Wei Chen, Xiao-Qiang Hou, Jing Zhang, Qing-Ping Chen, Chang-Lian Liu, Jia-Shun Zeng, Qing-Hua Zou, Yong-Fei Fang, Yin Su, Zhan-Guo Li, Ning-Ning Wang
Format: Article
Language:English
Published: Wolters Kluwer 2019-12-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000000570

Internet

http://journals.lww.com/10.1097/CM9.0000000000000570

Similar Items